Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, Q2 2011 by GlobalMarketsDirect

VIEWS: 7 PAGES: 62

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, Q2 2011

Summary

Global Markets Direct’s, 'Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, Q2 2011', provides an overview of the Post-Traumatic Stress Disorder (PTSD) therapeutic pipeline. This report provides information on the therapeutic development for Post-Traumatic Stress Disorder (PTSD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Post-Traumatic Stress Disorder (PTSD). 'Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, Q2 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Post-Traumatic Stress Disorder (PTSD).
- A review of the Post-Traumatic Stress Disorder (PTSD) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Post-Traumatic Stress Disorder (PTSD) pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

-

More Info
									Post-Traumatic Stress Disorder (PTSD) – Pipeline Review, Q2 2011




         Post-Traumatic Stress Disorder (PTSD) - Pipeline
                        Review, Q2 2011
                                                                                          Reference Code: GMDHC1099IDB

                                                                                          Publication Date: April 2011




Post-Traumatic Stress Disorder (PTSD) – Pipeline Review, Q2 2011                                                         GMDHC1099IDB / Pub April 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied
                                                                                                                                               Page(1)
Post-Traumatic Stress Disorder (PTSD) – Pipeline Review, Q2 2011



Ta b le o f Co n te n ts
Table of Contents                                                                                                                      2
List of Tables                                                                                                                         5
List of Figures                                                                                                                        6
Introduction                                                                                                                           7
     Global Markets Direct Report Coverage                                                                                             7
Post-Traumatic Stress Disorder (PTSD) Overview                                                                                         8
Therapeutics Development                                                                                                               9
     An Overview of Pipeline Products for Post-Traumatic Stress Disorder (PTSD)                                                        9
Post-Traumatic Stress Disorder (PTSD) Therapeutics under Development by Companies                                                     11
Post-Traumatic Stress Disorder (PTSD) Therapeutics under Investigation by Universities/Institutes                                     13
Late Stage Products                                                                                                                   15
     Comparative Analysis                                                                                                             15
Mid Clinical Stage Products                                                                                                           16
     Comparative Analysis                                                                                                             16
Early Clinical Stage Products                                                                                                         17
     Comparative Analysis                                                                                                             17
Discovery and Pre-Clinical Stage Products                                                                                             18
     Comparative Analysis                                                                                                             18
Post-Traumatic Stress Disorder (PTSD) Therapeutics - Products under Development by Companies                                          19
Post-Traumatic Stress Disorder (PTSD) Therapeutics - Products under Investigation by Universities/Institutes                          20
Companies Involved in Post-Traumatic Stress Disorder (PTSD) Therapeutics Development                                                  21
     Sanofi-Aventis                                                                                                                   21
     Nanotherapeutics, Inc.                                                                                                           21
     Addex Pharmaceuticals                                                                                                            22
     Biotie Therapies Corp.                                                                                                           22
     Azevan Pharmaceuticals, Inc.                                                                                                     23
     Marinus Pharmaceuticals, Inc.                                                                                                    23
     Naurex, Inc.                                                                                                                     24
Post-Traumatic Stress Disorder (PTSD) - Therapeutics Assessment                                                                       25
     Assessment by Monotherapy Products                                                                                               25
     Assessment by Route of Administration                                                                                            26
     Assessment by Molecule Type                                                                                                      28
Drug Profiles                                                                                                                         30
     Nepicastat - Drug Profile                                                                                                        30
          Product Description                                                                                                         30
          Mechanism of Action                                                                                                         30
          R&D Progress                                                                                                                30
     PRX-03140 - Drug Profile                                                                                                         31
          Product Description                                                                                                         31
          Mechanism of Action                                                                                                         31
          R&D Progress                                                                                                                31
     SSR125543 - Drug Profile                                                                                                         32
          Product Description                                                                                                         32
          Mechanism of Action                                                                                                         32
          R&D Progress                                                                                                                32
     SRX251 - Drug Profile                                                                                                            33
          Product Description                                                                                                         33


Post-Traumatic Stress Disorder (PTSD) – Pipeline Review, Q2 2011                                               GMDHC1099IDB / Pub April 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                                              Page(2)
Post-Traumatic Stress Disorder (PTSD) – Pipeline Review, Q2 2011


          Mechanism of Action                                                                                    33
          R&D Progress                                                                                           33
     SRX246 - Drug Profile                                                                                       34
          Product Description                                                                                    34
          Mechanism of Action                                                                                    34
          R&D Progress                                                                                           34
     Ketamine - Drug Profile                                                                                     35
          Product Description                                                                                    35
          Mechanism of Action                                                                                    35
          R&D Progress                                                                                           35
     D-serine - Drug Profile                                                                                     37
          Product Description                                                                                    37
          Mechanism of Action                                                                                    37
          R&D Progress                                                                                           37
     Propranolol - Drug Profile                                                                                  38
          Product Description                                                                                    38
          Mechanism of Action                                                                                    38
          R&D Progress                                                                                           38
     mGluR7 NAM Program - Drug Profile                                                                           39
          Product Description                                                                                    39
          Mechanism of Action                                                                                    39
          R&D Progress                                                                                           39
     GR205171 - Drug Profile                                                                                     40
          Product Description                                                                                    40
          Mechanism of Action                                                                                    40
          R&D Progress                                                                                           40
     Aprepitant - Drug Profile                                                                                   41
          Product Description                                                                                    41
          Mechanism of Action                                                                                    41
          R&D Progress                                                                                           41
     Duloxetine - Drug Profile                                                                                   42
          Product Description                                                                                    42
          Mechanism of Action                                                                                    42
          R&D Progress                                                                                           42
     Ganaxolone - Drug Profile                                                                                   43
          Product Description                                                                                    43
          Mechanism of Action                                                                                    43
          R&D Progress                                                                                           43
     Medicane (mifepristone) - Drug Profile                                                                      45
          Product Description                                                                                    45
          Mechanism of Action                                                                                    45
          R&D Progress                                                                                           45
     Levetiracetam - Drug Profile                                                                                46
          Product Description                                                                                    46
          Mechanism of Action                                                                                    46
          R&D Progress                                                                                           46
     Paroxetine-CR - Drug Profile                                                                                47
          Product Description                                                                                    47




Post-Traumatic Stress Disorder (PTSD) – Pipeline Review, Q2 2011                          GMDHC1099IDB / Pub April 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                         Page(3)
Post-Traumatic Stress Disorder (PTSD) – Pipeline Review, Q2 2011


          Mechanism of Action                                                                                                              47
          R&D Progress                                                                                                                     47
     3,4-methylenedioxymethamphetamine - Drug Profile                                                                                      48
          Product Description                                                                                                              48
          Mechanism of Action                                                                                                              48
          R&D Progress                                                                                                                     48
     Yohimbine - Drug Profile                                                                                                              49
          Product Description                                                                                                              49
          Mechanism of Action                                                                                                              49
          R&D Progress                                                                                                                     49
     Guanfacine - Drug Profile                                                                                                             50
          Product Description                                                                                                              50
          Mechanism of Action                                                                                                              50
          R&D Progress                                                                                                                     50
     Seromycin - Drug Profile                                                                                                              51
          Product Description                                                                                                              51
          Mechanism of Action                                                                                                              51
          R&D Progress                                                                                                                     51
     NRX-105x - Drug Profile                                                                                                               52
          Product Description                                                                                                              52
          Mechanism of Action                                                                                                              52
          R&D Progress                                                                                                                     52
     Propranolol - Drug Profile                                                                                                            53
          Product Description                                                                                                              53
          Mechanism of Action                                                                                                              53
          R&D Progress                                                                                                                     53
     Avlocardyl - Drug Profile                                                                                                             54
          Product Description                                                                                                              54
          Mechanism of Action                                                                                                   
								
To top